Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode
- Conditions
- Hearing DisordersDeafnessEar DiseasesHearing LossOtorhinolaryngologic Diseases
- Interventions
- Device: HiRes™ 90K Advantage implant with HiFocus™ Mid-Scala electrode
- Registration Number
- NCT01959152
- Lead Sponsor
- Advanced Bionics
- Brief Summary
The purpose of this study is to determine the feasibility of preserving low-frequency acoustic hearing in adults with a moderate degree of hearing loss in the low frequencies and severe-to-profound hearing loss in the mid-to-high frequencies who are implanted with the HiRes™ 90K Advantage implant with HiFocus™ Mid-Scala electrode.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 1
- No previous cochlear implant experience
- 18 years of age or older
- Up to a moderate sensorineural hearing loss in the low-to-mid frequencies (pure tone average ≤ 65 dB HL for 125, 250, 500, and 1000 Hz) and a severe-to-profound sensorineural hearing loss in the high frequencies (pure tone average ≥ 70 dB HL for 2,000, 4,000, and 8,000 Hz) in the ear to be implanted
- Aided monosyllabic word score of 10-50% in the ear to be implanted
- Up to a moderate sensorineural hearing loss in the low-to-mid frequencies (pure tone average ≤ 65 dB HL for 125, 250, 500, and 1000 Hz) and a severe-to-profound sensorineural hearing loss in the high frequencies (pure tone average ≥ 70 dB HL for 2,000, 4,000, and 8,000 Hz) in the contralateral (non-implanted) ear
- English language proficiency
- Willingness to participate in all scheduled procedures outlined in the protocol
- Previous inner ear surgery
- Cochlear malformation or obstruction that would preclude full insertion of electrode array
- Presence of additional disabilities that would prevent or interfere with participation in the required study procedures
- Medical or psychological conditions that contraindicate surgery or impact the ability to manage an implanted device or the study-related procedures
- Evidence of central auditory lesion or compromised auditory nerve
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description HiRes90K™ Advantage Cochlear Implant HiRes™ 90K Advantage implant with HiFocus™ Mid-Scala electrode HiRes90K™ Advantage implant with HiFocus™ Mid-Scala electrode will be implanted in adults with a moderate level of hearing loss in the low frequencies and severe-to-profound hearing loss in the mid-to-high frequencies.
- Primary Outcome Measures
Name Time Method Low-frequency unaided acoustic hearing thresholds pre and post implantation with the HiFocus™ Mid-Scala electrode array One month Unaided low-frequency acoustic hearing thresholds (under earphones) in the implanted ear one month after device activation will be compared to baseline (pre-implant) thresholds in the same ear for audiometric frequencies 125-1000Hz. Threshold changes from baseline will be calculated as:
* Complete preservation of hearing: threshold shift ≤ 15 dB
* Partial preservation of hearing: threshold shift ≥ 16 dB with measurable thresholds
* No preservation of hearing: no measurable thresholds at ≤ 80 dB HL
- Secondary Outcome Measures
Name Time Method Word recognition in quiet pre and post implantation with the HiFocus™ Mid-Scala electrode array One month Word recognition scores in quiet in the implanted ear one month after device activation compared to pre-implant score with a hearing aid
Trial Locations
- Locations (3)
Dalhousie University, Department of Surgery, Division of Otolaryngology
🇨🇦Halifax, Nova Scotia, Canada
The Ottawa Hospital, Parkdale Clinic, Audiology Department
🇨🇦Ottawa, Ontario, Canada
Sunnybrook Health Sciences Centre, Department of Otolaryngology - Head and Neck Surgery
🇨🇦Toronto, Ontario, Canada